Frenova Renal Research Launches Investigator Alliance
F1RST Up offers an exclusive alliance of 200 physician investigators, in nephrology, and accelerates study startup by eliminating the administrative and contracting burdens.
Frenova Renal Research has launched F1RST Up (Frenova Rapid STart Up), an exclusive alliance with clinical research sites selected from Frenova’s investigative site network of more than 200 physician investigators, which accelerates study startup by eliminating the administrative and contracting burdens. The investigators provide care to approximately 600,000 kidney disease patients, who have cardio-renal conditions, chronic kidney disease (CKD), end stage renal disease (ESRD), cardiovascular disease, rare diseases, and infectious diseases and transplant.
Read the full release.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
